Studies in patients with abetalipoproteinaemia, other chronic and severe fat malabsorptive states and a selective defect in vitamin E absorption, together with neuropathological studies in the vitamin E deficient human, monkey and rat indicate that vitamin E is important for normal neurological function. Appropriate vitamin E supplementation is, therefore, advisable for all patients with chronic fat malabsorption who have low serum vitamin E concentrations. Serum vitamin E concentrations should also be measured in patients with spinocerebellar disorders, whatever the aetiology.
Introduction
Vitamin E was discovered in 1922 when Evans and Bishop demonstrated the existence of a fat-soluble factor which was necessary for normal reproduction in the rat. Since that time a variety of vitamin E deficient syndromes have been produced experimentally in different animal species (Wasserman & Taylor, 1972) , but with the possible exception ofhaemolytic anaemia and oedema in some premature infants (Oski & Barness, 1967; Ritchie et al., 1968; Bell & Filer, 1981) the role of vitamin E in human nutrition has been the subject of much dispute. Research into the role of vitamin E in human nutrition has suffered from numerous and exaggerated claims which led Gordon et al. (1958) to describe vitamin E as 'a shady lady to be approached gingerly by respectable or discreet investigators in human nutrition'.
Over recent years, however, evidence has accumulated which indicates that the vitamin has an important function in the maintenance of normal neurological structure and function. The evidence comes from four principal sources; from patients with (a) abetalipoproteinaemia, (b) other chronic disorders of fat absorption, (c) an apparent selective defect in vitamin E absorption and (d) from comparative neuropathological studies in man and experimental animals. This evidence will be considered in turn.
Abetalipoproteinaemia
The clinical features of this rare inherited condition were first described by Bassen & Kornzweig in 1950. Ten years later three independent groups, one ofwhich included Professor Wolff. demonstrated the total absence of beta (low density) lipoprotein from the plasma of affected individuals (Lamy et al., 1960; Mabry et al., 1960; Salt et al., 1960) . It was subsequently shown that apoprotein B, the major apoprotein of low density lipoprotein was undetectable (Gotto et al., 1971) . As this apoprotein is also an essential component of prebeta (very low density) lipoproteins and chylomicrons, these lipoprotein species are also absent from the plasma of patients with abetalipoproteinaemia.
Amongst the clinical features of abetalipoproteniaemia are an ataxic neuropathy and pigmentary retinopathy which usually develop towards the end of the first decade oflife and are 'devastating' (Herbert et al., 1978) . In their paper, Wolff and colleagues suggested the possibility 'that these disturbances result from disordered fat absorption and transport' and went on to discuss vitamin A but not vitamin E as a possible candidate (Salt et al., 1960) .
It was subsequently shown that although low concentrations of serum vitamin E are found in many disorders of fat malabsorption (Figure 1 ), the most severe deficiency occurs in abetalipoproteinaemia in which the vitamin is undetectable in plasma when using a colorimetric assay (Kayden et al., 1965; Muller et al., 1974) or high performance liquid chromatrography and fluorimetry (D.P.R. Muller, unpublished observation). Thus abetalipoproteinaemia provided an ideal model for studying the effects of vitamin E deficiency in man. For this reason and also because the vitamin E deficient chick was known to develop a cerebellar disorder with ataxia (Pappenheimer & Goettsch, 1931) and neurological lesions had been described in several other animal species (Wasserman & Taylor, 1972) (Muller et al., 1974) .
After supplementation with large oral doses of vitamin E, absorption could be demonstrated in all eight patients. Serum concentrations, which were initially undetectable, became measureable although they never reached the normal range because of the absence of low density lipoprotein, a major carrier of the vitamin. In vitro haemolysis which was abnormally high in all patients in whom it was measured before treatment, fell to within normal limits in all eight patients after supplementation.
The long-term clinical results of vitamin E therapy in the eight patients have been reported in detail elsewhere (Muller et al., 1977; Muller & Lloyd, 1982; Runge et al., 1985) . The five patients who first received vitamin E supplements before the age of 16 months show no clinical abnormalities; motor nerve conduction studies and electrodiagnostic tests of retinal function remain normal. The three other patients (cases 6-8 of the previous reports) already showed some neurological dysfunction before supplementation with vitamin E in later childhood.
Patient 6 had absent tendon reflexes when diagnosed at 18 months ofage. He received vitamin E from the age of 3 years. At 11 years he had slight diminution in vibration sense in all limbs and by 18 he had minimal reduction in proprioception in the limbs and a slight reduction ofthe action potential in the sural and radial nerve but no other neurological or retinal abnormalities have developed. He now works in a car body repair workshop and attends a college of further education.
Patient 7 was the girl initially reported by Salt, Wolff and colleagues in 1960 . At diagnosis at the age of 18 months she had absent tendon reflexes; at 5 years she developed a mild pigmentary retinopathy, even though normal serum concentrations ofvitamin A had been maintained (Wolff et al., 1964 Other investigators have also reported the beneficial effects oflarge oral doses ofvitamin E in this condition (Azizi et al., 1978; Herbert et al., 1978; Miller et al., 1980; Hegele & Angel, 1985 (Harries & Muller, 1971) . A number of reports have now appeared relating a neurological syndrome to severe vitamin E deficiency in patients with a variety of chronic fat malabsorptive states. The majority ofthese reports have been in children with cholestatic liver diseases (Rosenblum et al., 1981; Elias et al., 1981; Guggenheim et al., 1982 Guggenheim et al., , 1983 Alvarez et al., 1983; Sokol et al., 1983) . The neurological features in abetalipoproteinaemia and in these patients with cholestasis are very similar (Muller et al., 1983) although it initially appeared that retinal changes were less common in the latter group. However, this may prove not to be the case as Alvarez et al. (1983) reported that all 13 children with cholestasis had abnormal electroretinograms and 4 of them showed various degrees of retinal degeneration. Most of the patients had normal serum vitamin A concentrations.
In general, patients with inadequate intestinal bile salt concentrations are unable to absorb oral supplements of vitamin E and require intramuscular preparations.
There have been reports of neurological improvement following such treatment (Guggenheim et al., 1982) .
A relationship between fat malabsorption, severe vitamin E deficiency and neurological sequelae has also been reported in adults with multiple ileal resections which result in impaired reabsorption of bile salts (Howard et al., 1982; Harding et al., 1982) and in a small number ofpatients with cystic fibrosis who had complications (multiple intestinal resections and liver disease) in addition to pancreatic insufficiency (Elias et al., 1981; Bye et al., 1985; Willison et al., 1985) .
Appropriate supplementation with vitamin E in some of these patients has also resulted in clinical improvement (Elias et al., 1981; Harding et al., 1982; Howard et al., 1982) .
Isolated defect of vitamin E absorption
There have recently been some case reports ofpatients with vitamin E deficiency and a similar neurological syndrome, but without evidence of generalized fat malabsorption (Malloy et al., 1981; Burck et al., 1981; Laplante et al., 1984; Harding et al., 1985) . The patient we described was a 23 year old woman who developed a progressive neurological disorder comprising ataxia, areflexia and marked loss of proprioception at the age of 14 (Muller & Lloyd, 1982) . Those patients with a selective defect of vitamin E absorption also indicate that there is good reason to include serum vitamin E estimations in the investigation of spinocerebellar syndromes developing in childhood or early adult life, particularly ifthe clinical features are similar to that found in abetalipoproteinaemia.
Neuropathological studies
Neuropathological studies have been reported in the vitamin E deficient human, rat and monkey. In all three species degeneration ofthe axons ofthe posterior columns and a selective loss oflarge calibre myelinated sensory axons in the spinal cord and peripheral nerves, which is particularly severe in the posterior columns, has been reported (Nelson et al., 1981) . As a result of these observations, Nelson et al. (1981) suggested that chronic and severe vitamin E deficiency in the rat, monkey, and human leads to degeneration and loss of sensory axons in the posterior columns, sensory roots, and peripheral nerves. He also concluded that this degeneration results from axonal membrane injury and then develops as a distal and dying-back type of axonopathy.
Additional evidence to support a causal relationship between vitamin E deficiency and neurological lesions comes from the observations of Sung (1964) and Sung et al. (1980) . They found that the incidence at necropsy of axonal dystrophy in the gracile nucleus of patients with cystic fibrosis who died between 1970 and 1980 was lower than that for similar patients dying between 1952 and 1969. This fall coincided with the introduction of vitamin E supplementation into the management of patients with cystic fibrosis in the mid1960s.
Mechanism of action
The mode of action ofvitamin E in the nervous system has not been estalished. In vitro, and probably in vivo, it acts as an antioxidant and it appears that it is the only significant lipid-soluble, chain-breaking type of antioxidant present in human blood (Burton et al., 1983) . The neuropathological findings support the concept that it is important for the maintenance of the integrity and stability of biological membranes and one postulate is that it protects the phospholipids of biological membranes from peroxidation. It could also be important in maintaining other molecules in their correct oxidation state.
An intriguing question is why the axonal membrane is particularly susceptible to a deficiency of this vitamin. Cavanagh (1984) has pointed out the logistical problems of neurones with long axons, whereby the cell body has to maintain the very large surface area of the axonal membrane. The axonal membrane may therefore be particularly susceptible to free radical attack if its antioxidant mechanisms are compromised, and the longest fibres would be expected to be the first to suffer. Cavanagh also compared the axonal membrane to that of the red blood cell which is separated from its source of metabolites in time rather than distance and pointed out that the latter is highly dependent on the antioxidant-reduced glutathione.
In order to gain an understanding of the mechanisms involved we (Goss Sampson et al., 1985) and others (Vatassery et al., 1984) have begun to investigate the neurobiology of vitamin E and other antioxidant systems in man and experimental animals.
The vitamin E concentration varies in different neuroanatomical regions, and in the brain the cerebral cortex has the highest and the cerebellum the lowest concentration of the vitamin.
Treatment with vitamin E
The evidence linking vitamin E deficiency with neurological abnormalities is now sufficiently strong to recommend vitamin E supplementation for all patients with chronic fat malabsorption who have reduced serum concentrations of the vitamin. It is, however, essential that the vitamin should be administered appropriately and this will vary with different patient groups. A recent study has shown that in adults with cystic fibrosis (except those with grossly abnormal liver function) an oral dose of 10mg/kg/day for at least one month followed by a maintenance dose of 200 mg/day (i.e. 1 tablet of tocopheryl acetate-Ephynal) is normally adequate to maintain serum concentrations ofvitamin E within the normal range. In patients with abetalipoproteinaemia, however, it is necessary to give very large oral doses of about 100 mg/kg/day if an adequate vitamin E status is to be achieved. In patients with greatly reduced luminal bile salt concentrations, it is likely that oral preparations will not be absorbed and that the vitamin will have to be given intramuscularly. However, before embarking on long-term, regular, intramuscular treatment it is our practice to assess intestinal absorption by giving a large oral load (1-2g) of tocopheryl acetate and monitoring serum concentrations of the vitamin at regular intervals over the following 24 hours. Ifthere is evidence ofabsorption, asjudged by a significant increase in serum concentrations, large oral doses are given and serum levels carefully monitored to ensure that normal concentrations are reached and maintained. If no absorption of the oral load can be documented intramuscular therapy should be given. 
